Pharmaxis Applies to Market Bronchitol for Cystic Fibrosis in Europe
29th
Oct 09
Release Date: 29/10/2009 12:00am
Pharmaxis has filed an application with the European Medicines Agency (EMeA) to market Bronchitol in Europe for the treatment of cystic fibrosis.
Categories: News and Media